Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding - A Multicenter Study, Randomized, Double-Blind, Placebo Control
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Urinary incontinence
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2017 Status changed from recruiting to completed.
- 03 Feb 2017 Planned End Date changed from 1 Dec 2014 to 1 Feb 2017.
- 03 Feb 2017 Planned primary completion date changed from 1 Dec 2014 to 1 Feb 2017.